Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO)
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of intravitreal Lucentis® (Ranibizumab)
and investigate the anatomical and functional improvement following this treatment in
patients with macular edema due to retinal vein occlusion (RVO).